Comparison of Overall Function Between Postpartum Women With and Without Diastasis Rectus Abdominis
NCT ID: NCT05709704
Last Updated: 2023-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
150 participants
OBSERVATIONAL
2021-07-02
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Mobile App-Based Exercises on Rectus Diastasis in Women Undergoing Cesarean Birth
NCT07001046
Abdominal Trunk Function After Surgical Repair of Abdominal Rectus Muscle Diastasis
NCT03623594
Hypopressive Abdominal Exercise in Postpartum Abdominal Diastasis
NCT04238156
Diastasis Recti Abdominis Association With Sacroiliac Joint and Pelvic Floor Dysfunction in Postpartum C-section Women
NCT04519840
Low Back Pain Intensity and Core Muscle Strength After Different Delivery Modes
NCT05493891
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* The investigators will place recruitment fliers in local obstetrician offices, labor and delivery units in local hospitals, retail and daycare establishments, and on social media outlets such as Facebook, Instagram and Twitter.
* The recruitment fliers will ask interested women to email a student investigator to enroll in the research project.
Step 2: Collection of functional outcome data using a Qualtrics version of the Inventory of Functional Status After Childbirth (IFSAC), a demographic survey, a numeric pain reporting scale, Oswestry Low Back Pain Disability Questionnaire, and the Pelvic Floor Distress Index.
Step 3: A meeting time will be set up with every participant to conduct a telehealth visit with a research assistant. During this virtual visit on a private, password protected Zoom call the participant will be instructed on self-assessment palpation of the abdominal wall in order to determine the presence or absence of diastasis rectus abdominis (DRA) along the inter-rectus distance (IRD).
Step 4: The first 18 participants with self-assessed DRA and the first 18 participants without self-assessed DRA, who live in Wichita or surrounding areas, will be scheduled for a one-time in-person confirmation appointment. The appointment will last a maximum of 15 minutes and occur at the WSU Old Town campus room A106. During this confirmation appointment research assistants will screen the participant with the COVID Pre-screening Questions Tool, obtain written informed consent, check the participant in, collect height and weight, and the principal investigator will measure the participants abdominal wall using real-time ultrasound, measure the IRD using the PI's palpation method, and ask the participant to demonstrate and measure IRD using the same palpation method used on the telehealth visit. See the virus protection plan for details of which all participants and investigators will follow in order to minimize risks related to COVID-19).
Step 5: The data will be entered into SPSS and analyzed with appropriate statistical analyses.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Postpartum Women WITH DRA
Participants who have the diagnosis of diastasis rectus abdominis
Self-palpation via telehealth
This will be used to determine if the participant has the diagnosis
Real-time Ultrasound
This will be used in a subgroup of participants to confirm/rule out a diagnosis
Postpartum Women WITHOUT DRA
Participants who do not have a diagnosis of diastasis rectus abdominis
Self-palpation via telehealth
This will be used to determine if the participant has the diagnosis
Real-time Ultrasound
This will be used in a subgroup of participants to confirm/rule out a diagnosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self-palpation via telehealth
This will be used to determine if the participant has the diagnosis
Real-time Ultrasound
This will be used in a subgroup of participants to confirm/rule out a diagnosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Postpartum (within 6-10 weeks of vaginal delivery)
Exclusion Criteria
* Women who had high-risk pregnancies (bedrest, gestational diabetes, pregnancy-induced hypertension)
* Women with a history of abdominal or back surgery
* Women with history of connective tissue disease such as Ehlers-Danlos Syndrome
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wichita State University
OTHER
Texas Woman's University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wichita State University
Wichita, Kansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-FY2021-405
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.